Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes

Background The analysis of electronic health records for an automated detection of adverse drug reactions is an approach to solve the problems that arise from traditional methods like spontaneous reporting or manual chart review. Algorithms addressing this task should be modeled on the criteria for a standardized case causality assessment defined by the World Health Organization. One of these criteria is the temporal relationship between drug intake and the occurrence of a reaction or a laboratory test abnormality. Appropriate data that would allow for developing or validating related algorithms is not publicly available, though. Methods In order to provide such data, retrospective routine data of drug administrations and temporally corresponding laboratory observations from a university clinic were extracted, transformed and evaluated by experts in terms of a reasonable time relationship between drug administration and lab value alteration. Result The result is a data corpus of 400 episodes of normalized laboratory parameter values in temporal context with drug administrations. Each episode has been manually classified whether it contains data that might indicate a temporal correlation between the drug administration and the change of the lab value course, whether such a change is not observable or whether a decision between those two options is not possible due to the data. In addition, each episode has been assigned a concordance value which indicates how difficult it is to assess. This is the first open data corpus of a computable ground truth of temporal correlations between drug administration and lab value alterations. Discussion The main purpose of this data corpus is the provision of data for further research and the provision of a ground truth which allows for comparing the outcome of other assessments of this data with the outcome of assessments made by human experts. It can serve as a contribution towards systematic, computerized ADR detection in retrospective data. With this lab value curve data as a basis, algorithms for detecting temporal relationships can be developed, and with the classification made by human experts, these algorithms can immediately be validated. Due to the normalization of the lab value data, it allows for a generic approach rather than for specific or solitary drug/lab value combinations.

[1]  K Irjala,et al.  Using computerized individual medication data to detect drug effects on clinical laboratory tests. , 1995, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[2]  Thomas Bürkle,et al.  Adverse drug events in patients admitted to an emergency department: an analysis of direct costs , 2015, Pharmacoepidemiology and drug safety.

[3]  Klaus Krippendorff,et al.  Computing Krippendorff's Alpha-Reliability , 2011 .

[4]  Klaus Krippendorff,et al.  Content Analysis: An Introduction to Its Methodology , 1980 .

[5]  W. A. Scott,et al.  Reliability of Content Analysis ; The Case of Nominal Scale Cording , 1955 .

[6]  T. Bürkle,et al.  E‐pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions , 2013, British journal of clinical pharmacology.

[7]  Nigam H. Shah,et al.  Using Temporal Patterns in Medical Records to Discern Adverse Drug Events from Indications , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

[8]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[9]  Sowmya R. Rao,et al.  Use of electronic health records in U.S. hospitals. , 2009, The New England journal of medicine.

[10]  W. Curran.  The thalidomide tragedy in Germany: the end of a historic medicolegal trial. , 1971, The New England journal of medicine.

[11]  A. Borobia,et al.  A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients , 2010, Clinical pharmacology and therapeutics.

[12]  A. Pakarinen,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.

[13]  Klaus Krippendorff,et al.  Answering the Call for a Standard Reliability Measure for Coding Data , 2007 .

[14]  Y. Hayashi.  [Drug effects on laboratory test results]. , 1989, Nihon rinsho. Japanese journal of clinical medicine.

[15]  Griffin M. Weber,et al.  Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) , 2010, J. Am. Medical Informatics Assoc..

[16]  D. Classen,et al.  'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. , 2011, Health affairs.

[17]  J. Fleiss.  Measuring nominal scale agreement among many raters. , 1971 .

[18]  Torbjørn Torsvik,et al.  Presentation of clinical laboratory results: an experimental comparison of four visualization techniques , 2012, J. Am. Medical Informatics Assoc..

[19]  R. Altman,et al.  Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.

[20]  E. Cohen.  Use of Electronic Health Records in U.S. Hospitals , 2010 .

[21]  Klaus Krippendorff,et al.  Estimating the Reliability, Systematic Error and Random Error of Interval Data , 1970 .

[22]  Z. Bankowski,et al.  Council for International Organizations of Medical Sciences , 1991 .